Lifestyles: The Costs Of The Obesity Epidemic

Lifestyles: The Costs Of The Obesity Epidemic

Research  these Stocks on Kapitall’s Playground Now

 
research now

Numbers released by the Mayo Clinic suggest obesity costs more than smoking. The data shows that smokers’ medical costs were $1,275 more than the average non-smoking person’s, but obese people’s costs an additional $1,275, and morbidly obese people cost up to $5,500 more each year, according to Business Insider. Mayo’s James Naessens said that smoking added about 20% a year to medical costs with obesity being similar, but morbid obesity added about 50% a year.

Sharon Begley at Reuters reports that obesity costs twice what was previously estimated due to remodeling to accommodate obese people. For example, a billion gallons more gasoline is burned each year (more fuel to carry more weight) than what would be if people weighed the same as in 1960. Reuters also mentions that the U.S. healthcare reform of 2010 allows employers to charge obese patients 30-50% more if they don’t participate in a wellness program.

It was also stated that obese employees are less productive than healthy-weighted employees because they tend to miss more days of work. The lower productivity has an affect on income as well, according to a study led by Timothy Judge at University of Florida and published by the American Psychological Association.

Business Section: Investing Ideas

The money from increased costs in healthcare for obesity has to go somewhere.

Below is a list of healthcare companies that are undervalued by leveraged free cash flow. Do you think these names will see some of that money?

Interactive Chart: Use the Compar-O-Matic to compare analyst ratings for the stocks mentioned below:

List sorted by market cap.

 

“1. Pfizer Inc. (PFE, Earnings, Analysts, Financials): A biopharmaceutical company, offers prescription medicines for humans and animals worldwide. Market cap at $173.96B, most recent closing price at $22.99. Levered free cash flow at $20.90B vs. enterprise value at $186.28B (implies a LFCF/EV ratio at 11.22%).

 

“2. AstraZeneca PLC (AZN, Earnings, Analysts, Financials): Develops, and commercializes prescription medicines for cardiovascular, gastrointestinal, infection, neuroscience, oncology, and respiratory and inflammation diseases worldwide. Market cap at $55.34B, most recent closing price at $43.86. Levered free cash flow at $6.72B vs. enterprise value at $53.79B (implies a LFCF/EV ratio at 12.49%).

 

“3. WellPoint Inc. (WLP, Earnings, Analysts, Financials): Operates as a health benefits company in the United States. Market cap at $22.7B, most recent closing price at $68.36. Levered free cash flow at $3.17B vs. enterprise value at $13.73B (implies a LFCF/EV ratio at 23.09%).

 

“4. Cigna Corp. (CI, Earnings, Analysts, Financials): Operates as a health service organization. Market cap at $13.47B, most recent closing price at $46.38. Levered free cash flow at $1.60B vs. enterprise value at $13.61B (implies a LFCF/EV ratio at 11.76%).

 

“5. Warner Chilcott plc (WCRX, Earnings, Analysts, Financials): Focuses on the development, manufacture, and promotion of branded pharmaceutical products in women's healthcare, gastroenterology, dermatology, and urology segments in North America and western Europe markets. Market cap at $5.44B, most recent closing price at $21.81. Levered free cash flow at $1.22B vs. enterprise value at $7.93B (implies a LFCF/EV ratio at 15.38%).

 

“6. Hill-Rom Holdings, Inc. (HCR, Earnings, Analysts, Financials): Provides medical technologies and related services for the health care industry in the United States and internationally. Market cap at $2.03B, most recent closing price at $32.53. Levered free cash flow at $196.80M vs. enterprise value at $1.92B (implies a LFCF/EV ratio at 10.25%).

 

“7. ViroPharma Inc. (VPHM, Earnings, Analysts, Financials): Engages in the development and commercialization of products that address serious diseases with a focus on products used by physician specialists or in hospital settings in the United States and internationally. Market cap at $1.54B, most recent closing price at $22.03. Levered free cash flow at $160.56M vs. enterprise value at $1.25B (implies a LFCF/EV ratio at 12.84%).

 

“8. Molina Healthcare Inc. (MOH, Earnings, Analysts, Financials): Provides Medicaid-related solutions to meet the health care needs of low-income families and individuals, as well as assists state agencies in their administration of the Medicaid program. Market cap at $1.23B, most recent closing price at $26.51. Levered free cash flow at $100.00M vs. enterprise value at $602.09M (implies a LFCF/EV ratio at 16.61%).

 

“9. AmSurg Corp. (AMSG, Earnings, Analysts, Financials): Engages in the development, acquisition, and operation of ambulatory surgery centers in partnership with physicians in the United States. Market cap at $905.88M, most recent closing price at $28.76. Levered free cash flow at $136.42M vs. enterprise value at $1.34B (implies a LFCF/EV ratio at 10.18%).

 

“10. PDL BioPharma, Inc. (PDLI, Earnings, Analysts, Financials): Engages in the management of antibody humanization patents and royalty assets, which consist of Queen et al. Market cap at $879.81M, most recent closing price at $6.26. Levered free cash flow at $184.62M vs. enterprise value at $1.07B (implies a LFCF/EV ratio at 17.25%).

 

 

(Written by Danny Guttridge. Data sourced from Finviz)

 

Use Kapitall's Tools: Looking for ways to analyze this list?

Use this article snapshot as a launch pad (click here for help): Simply click on the links, and use Kapitall's tab navigation to browse through the data…

 

Analyze These Ideas: Getting Started

Dig Deeper: Access Company Snapshots, Charts, Filings

New to Kapitall?

1. New to the site? Click here to register for a free account, and gain access to more tools and data
2. Looking for more investing ideas like this? Click here to sign up for your free copy of Kapitall Weekly
3. Follow us on SeekingAlpha, Motley Fool, Nasdaq and Twitter

 

 

 

playthemarketnopromo6401362png

Leave a Reply

Protected by WP Anti Spam

playthemarketnopromo2802202png